The price-to-earnings ratio for Bruker Corp (NASDAQ: BRKR) is above average at 24.32x. The 36-month beta value for BRKR is also noteworthy at 1.18. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 10 rating it as “hold,” and 1 rating it as “sell.”
The public float for BRKR is 102.91M, and at present, short sellers hold a 4.22% of that float. The average trading volume of BRKR on October 31, 2024 was 1.14M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BRKR) stock’s latest price update
Bruker Corp (NASDAQ: BRKR)’s stock price has gone rise by 0.79 in comparison to its previous close of 58.05, however, the company has experienced a -1.96% decrease in its stock price over the last five trading days. zacks.com reported 2024-10-29 that Bruker (BRKR) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRKR’s Market Performance
Bruker Corp (BRKR) has experienced a -1.96% fall in stock performance for the past week, with a -12.36% drop in the past month, and a -14.37% drop in the past quarter. The volatility ratio for the week is 2.09%, and the volatility levels for the past 30 days are at 2.78% for BRKR. The simple moving average for the last 20 days is -5.68% for BRKR’s stock, with a simple moving average of -19.01% for the last 200 days.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with Barclays repeating the rating for BRKR by listing it as a “Overweight.” The predicted price for BRKR in the upcoming period, according to Barclays is $75 based on the research report published on October 15, 2024 of the current year 2024.
Wells Fargo gave a rating of “Overweight” to BRKR, setting the target price at $78 in the report published on August 28th of the current year.
BRKR Trading at -9.18% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.32% of loss for the given period.
Volatility was left at 2.78%, however, over the last 30 days, the volatility rate increased by 2.09%, as shares sank -13.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.10% lower at present.
During the last 5 trading sessions, BRKR fell by -1.96%, which changed the moving average for the period of 200-days by -17.50% in comparison to the 20-day moving average, which settled at $62.03. In addition, Bruker Corp saw -20.37% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from ROSENTHAL BOB, who sale 4,684 shares at the price of $63.14 back on Aug 15 ’24. After this action, ROSENTHAL BOB now owns 30,963 shares of Bruker Corp, valued at $295,748 using the latest closing price.
ROSENTHAL BOB, the Director of Bruker Corp, proposed sale 4,684 shares at $61.47 during a trade that took place back on Aug 15 ’24, which means that ROSENTHAL BOB is holding shares at $287,925 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.5 for the gross margin
The net margin for Bruker Corp stands at 0.11. The total capital return value is set at 0.08. Equity return is now at value 23.31, with 7.22 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 1.21. The interest coverage ratio of the stock is 36.65.
Currently, EBITDA for the company is 597.2 million with net debt to EBITDA at 3.9. When we switch over and look at the enterprise to sales, we see a ratio of 3.51. The receivables turnover for the company is 4.49for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.
Conclusion
In summary, Bruker Corp (BRKR) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
